MEAKSS, a synthetic heptapeptide, is emerging as a promising agent for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates potent neuroprotective effects by regulating key cellular pathways involved in neuronal maintenance. Studies suggest that MEAKSS can enhance neuronal growth, {reduceinflammation, and augment co